期刊文献+

血管内皮生长因子、Eph受体酪氨酸激酶A2、基质金属蛋白酶-2和-9在卵巢癌血管生成拟态中的作用 被引量:7

Effects of vascular endothelial growth factor,Eph receptor A2,matrix metalloproteinase-2 and-9 in ovarian carcinoma vasculogenic mimicry
下载PDF
导出
摘要 目的探讨血管内皮生长因子(VEGF)、Eph受体酪氨酸激酶A2(EphA2)、基质金属蛋白酶(MMP)-2和MMP-9在卵巢癌血管生成拟态中的作用。方法收集临床和预后资料完整的卵巢癌组织标本84例,切片经明确诊断后进行CD31和过碘酸-雪夫(PAS)双重染色,证实肿瘤组织中存在血管生成拟态,行VEGF、EphA2、MMP-2和MMP-9免疫组织化学染色,根据染色指数统计免疫组织化学染色结果。结果有血管生成拟态组(36/84)和无血管生成拟态组卵巢癌组织(48/84)的VEGF、EphA2、MMP-9表达差异有统计学意义,有血管生成拟态组的卵巢癌细胞VEGF、EphA2、MMP-9表达明显高于无血管生成拟态组。但有血管生成拟态组和无血管生成拟态组患者的MMP-2表达差异无统计学意义。结论在卵巢癌中血管生成拟态和内皮依赖性血管并存,VEGF、EphA2和MMP-9等参与了卵巢癌血管生成拟态的形成。检测VEGF、EphA2和MMP-9可作为预测卵巢癌预后的间接指标。 Objective To investigate the effect of vascular endothelial growth factor (VEGF), Eph receptor A2 (EphA2) , matrix metalloproteinases(MMP)-2 and MMP-9 in ovarian carcinoma vasculogenic mimicry( VM). Methods Totally 84 ovarian carcinoma specimens with complete clinical and prognostic data were collected, and using CD31 and PAS double staining to confirm if vasculogenic mimicry exists in the ovarian carcinoma specimens. Immunohistochemical method was used to detect VEGF, EphA2, MMP-2 and MMP-9, examining the results of the immunohistochemical method according to the dye index. Results VEGF, EphA2 and MMP-9 in ovarian carcinoma specimens had significant differences between the VM group (36/84) and non-VM group (48/84), the expression in the VM group showed significantly higher than that in non-VM group. But the expression of MMP-2 between the two groups was not statistically significant. Conclusion Vasculogenic mimicry and endothelium-derived angiogenesis are co-existed in ovarian carcinoma, VEGF, EphA2 and MMP-9 play important roles in vasculogenic mimicry. Detecting VEGF, EphA2 and MMP-9 can be used to evaluate the prognosis of ovarian carainoma.
出处 《解剖学报》 CAS CSCD 北大核心 2011年第3期378-383,共6页 Acta Anatomica Sinica
基金 天津市应用基础及前沿技术研究资助项目(10JCYBJC12900)
关键词 卵巢癌 血管生成拟态 血管内皮生长因子 Eph受体酪氨酸激酶A2 基质金属蛋白酶 免疫组织 化学 Ovarian carcinoma Vasculogenic mimicry Vascular endothelial growth factor Eph receptor A2 Matrix metalloproteinase Immnnohistochemistry Human
  • 相关文献

参考文献13

  • 1Maniotis AJ,Folberg R,Hess A,et al.Vascular channel formation by human melanoma cells in vivo and in vitro:vasculogenic mimicry[J].Am J Pathol,1999,155(3):739-752.
  • 2Sun B,Zhang S,Zhang D,et al.Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer[J].Clin Cancer Res,2008,14(21):7050-7059.
  • 3Byrne AM,Bouchier-Hayes DJ,Harmey JH.Angiogenic and cell survival functions of vascular endothelial growth factor[J].J Cell Mol Med,2005,9(4):777-794.
  • 4Sun B,Zhang D,Zhang S,et al.Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma[J].Cancer Lett,2007,249(2):188-197.
  • 5Brantley-Sieders DM,Fang WB,Hicks DJ,et al.Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression[J].FASEB J,2005,19(13):1884-1886.
  • 6Zelinski DP,Zantek ND,Stewart JC,et al.EphA2 overexpression causes tumorigenesis of mammary epithelial cells[J].Cancer Res,2001,61(5):2301-2306.
  • 7Walker-Daniels J,Hess AR,Hendrix MJ,et al.Differential regulation of EphA2 in normal and malignant cells[J].Am J Pathol,2003,162(4):1037-1042.
  • 8Ireton RC,Chen J.EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics[J].Curr Cancer Drug Targets,2005,5(3):149-157.
  • 9D'Amico TA,Aloia TA,Moore MB,et al.Predicting the sites of metastases from lung cancer using molecular biologic markers[J].Ann Thorac Surg,2001,72(4):1144-1148.
  • 10Easty DJ,Bennett DC.Protein tyrosine kinases in malignant melanoma[J].Melanoma Res,2000,10(5):401-411.

同被引文献75

  • 1Hiroaki Itamochi.Targeted therapies in epithelial ovarian cancer: Molecular mechanisms of action[J].World Journal of Biological Chemistry,2010,1(7):209-220. 被引量:14
  • 2李凌江,李则宣.精神应激的生物学致病机制研究-II:神经内分泌机制[J].中国行为医学科学,2005,14(2):156-158. 被引量:39
  • 3符淳,李光仪.腹腔镜手术应用于卵巢恶性肿瘤的进展及前景[J].实用妇产科杂志,2007,23(4):205-207. 被引量:12
  • 4Fromowitz F B, Viola M V, Chao S, et al. Ras p21 expression in the progression of breast cancer [J]. Hum Pathol, 1987,18(12) : 1268-1275.
  • 5Pei L, Melmed S. Isolation and characterization of a pituitary tumor transforming gene (PTTG) [J]. Mol Endocrinol, 1997,11 (4) :433-441.
  • 6McCabe C J, Gittoes N J. PTTG-a new pituitary tumour trans- forming gene[J]. J Endocrinol, 1999,162(2):163-166.
  • 7Kim D S, Franklyn J A, Stratford A L, et al. Pituitary tumor- transforming gene regulates multiple downstream angiogenic genes in thyroid cancer [J]. J Clin Endocrinol Metab, 2006,91 (3) : 1119-1128.
  • 8Fielding A B, Dedhar S. The mitotic functions of integrin-linked kinase [J]. Cancer Metastasis Rev, 2009,28(1-2) : 99-111.
  • 9Wang S, Basson M D. Integrin-linked kinase: a multi-functional regulator modulating extracellular pressure-stimulated cancer cell adhesion through focal adhesion kinase and AKT [J]. Cell Oncol, 2009,31 (4) : 273-289.
  • 10Goulioumis A K, Bravou V, Varakis J, et al. Integrin-linked ki- nase cytoplasmic and nuclear expression in laryngeal carcinomas[J]. Virehows Arch, 2008,453(5) :511-519.

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部